Passage Bio, Inc.
NASDAQ:PASG
7.1799 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.081 | 3.721 | 3.679 | 1.543 | 0.8 | 0.134 | 0 |
| Gross Profit
| -3.081 | -3.721 | -3.679 | -1.543 | -0.8 | -0.134 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 40.179 | 59.556 | 86.053 | 117.673 | 81.788 | 29.738 | 9.167 |
| General & Administrative Expenses
| 24.988 | 41.58 | 49.341 | 60.056 | 30.114 | 6.951 | 0.928 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 24.988 | 41.58 | 49.341 | 60.056 | 30.114 | 6.951 | 0.928 |
| Other Expenses
| 0 | -4.721 | 0 | -1.543 | -0.8 | 0 | 0 |
| Operating Expenses
| 65.167 | 96.415 | 135.394 | 176.186 | 111.102 | 36.689 | 10.095 |
| Operating Income
| -70.4 | -100.136 | -138.394 | -185.729 | -112.902 | -37.189 | -13.466 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 5.633 | -1.926 | 2.269 | 0.343 | 0.67 | -8.445 | 0.696 |
| Income Before Tax
| -64.767 | -102.062 | -136.125 | -185.386 | -112.232 | -45.634 | -12.77 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | -0.47 | 0 | 0 |
| Net Income
| -64.767 | -102.062 | -136.125 | -185.386 | -112.232 | -45.634 | -12.77 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -21.44 | -37.29 | -50.02 | -69.51 | -57.8 | -45.6 | -10.6 |
| EPS Diluted
| -21.44 | -37.29 | -50.02 | -69.51 | -57.8 | -45.6 | -10.6 |
| EBITDA
| -61.686 | -98.341 | -132.446 | -183.843 | -111.432 | -36.555 | -7.42 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |